Kimia Biosciences Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	96.12	-53.09	-93.52	-37.03	51.04
Depreciation & Amortization	33.6	32.44	32.73	28.96	18.74
Other Amortization	0.19	0.49	0.6	0.45	0.36
Loss (Gain) From Sale of Assets	-	-	-	-0.79	-0.37
Loss (Gain) From Sale of Investments	-	-0	-0.03	-0.02	-0.41
Provision & Write-off of Bad Debts	-	-	2.41	-	-
Other Operating Activities	75.19	26.14	10.1	17.12	22.08
Change in Accounts Receivable	-101.36	39.15	10.81	92.51	-53.47
Change in Inventory	-37.8	174.3	-112.16	-133.31	-33.75
Change in Accounts Payable	145.64	-77.14	81.37	112.09	55.44
Change in Other Net Operating Assets	1.56	3.06	-	-	-
Operating Cash Flow	213.14	145.35	-67.7	79.97	59.67
Operating Cash Flow Growth	46.64%	-	-	34.02%	1834.20%
Capital Expenditures	-45.99	-15.07	-28.12	-35.8	-135.61
Sale of Property, Plant & Equipment	-	-	-	20.67	0.5
Investment in Securities	-	0.63	-	-	4
Other Investing Activities	-1.02	-0.5	0.13	8.03	-4.92
Investing Cash Flow	-47.01	-14.93	-27.99	-7.1	-136.03
Short-Term Debt Issued	2.05	-	50.22	-	68.06
Long-Term Debt Issued	54.04	13.4	170.42	123.43	166.56
Total Debt Issued	56.08	13.4	220.63	123.43	234.62
Short-Term Debt Repaid	-	-0.92	-	-15.58	-
Long-Term Debt Repaid	-164.43	-107.66	-97.6	-150.99	-129.93
Total Debt Repaid	-164.43	-108.58	-97.6	-166.57	-129.93
Net Debt Issued (Repaid)	-108.35	-95.18	123.04	-43.14	104.69
Other Financing Activities	-57.2	-35.54	-27.62	-33.54	-24.79
Financing Cash Flow	-165.55	-130.72	95.41	-76.68	79.91
Net Cash Flow	0.59	-0.3	-0.27	-3.82	3.55
Free Cash Flow	167.15	130.28	-95.82	44.17	-75.94
Free Cash Flow Growth	28.30%	-	-	-	-
Free Cash Flow Margin	14.06%	12.42%	-7.46%	3.54%	-5.72%
Free Cash Flow Per Share	3.53	2.75	-2.02	0.93	-1.60
Cash Interest Paid	57.2	35.54	27.62	33.54	24.79
Cash Income Tax Paid	-0.52	-0.25	-0.14	0.69	-0.42
Levered Free Cash Flow	54.08	114.12	-67.59	56.5	-147.11
Unlevered Free Cash Flow	76.16	141.91	-44.21	75.88	-131.62
Change in Working Capital	8.04	139.37	-19.98	71.28	-31.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.